Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 8 medicines
FDA · 5 medicines
AEMPS · 4 medicines
AIFA · 3 medicines
SFDA · 2 medicines · Historical list
HSA · 2 medicines
PHARMAC · 1 medicine
TFDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Clobazam | United States | 10MG, 20MG, 5MG | tablet | Marketed | Lupin |
| Clobazam | United States | 2.5MG/ML | suspension | Marketed | Teva Pharms USA |
| Sympazan | United States | 10MG, 20MG, 5MG | film | Marketed | Assertio Speclty |
| Onfi | United States | 10MG, 20MG, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Marketed | Lundbeck Pharms LLC |
| Onfi | United States | 2.5MG/ML | suspension | Marketed | Lundbeck Pharms LLC |
The same brand on several registers.
The companies holding its medicines, the most first.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
